Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0532-2026Class I

SJM Pericardial Patch, with EnCap Technology 5x10 cm, Model Number REF C0510; PATCH, PLEDGET AND...

Glycar SA Pty., Ltd. / initiated 2025-10-09 / Open, Classified / root cause: manufacturing process

Glycar SA Pty., Ltd. began a recall of SJM Pericardial Patch, with EnCap Technology 5x10 cm, Model Number REF C0510; PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE on . FDA classified it as Class I and gives the reason as "The impacted lot may not meet the required tensile strength specification". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0532-2026
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Glycar SA Pty., Ltd.
Product
SJM Pericardial Patch, with EnCap Technology 5x10 cm, Model Number REF C0510; PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE
Product code
DXZ Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene
Reason for recall
The impacted lot may not meet the required tensile strength specification.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Glycar issued a Stock Withdrawal Notification to its sole distributor on 10/09/2025. The notice explained the issue and requested the following: "Required Actions 1. Immediately identify and segregate all affected stock in your possession. 2. Clearly label the identified stock as "WITHDRAWN PRODUCT" DO NOT DISTRIBUTE OR USE. 3. Suspend any further distribution or transfer of the affected lots. 4. Provide written confirmation of the quantity and storage location of all affected stock within five (5) business days of receipt of this notification. 5. Our Quality team will coordinate collection, return, or replacement of affected product as appropriate." For questions or require further clarification, contact: Malcolm Applewhite, [email protected] On 10/17/2025, the firm issued an URGENT: MEDICAL DEVICE RECALL notice the medical facility via email. This notice explained the issue, potential risk to health, and requested the following: "Actions to be Taken by the Customer / User: 1. Identify and quarantine any affected products with lot number T2502257 in your possession. 2. Cease use of the affected device immediately. 3. Share this notice with applicable personnel within your institution. 4. Abbott will coordinate and arrange for return and replacement of affected units. 5. Complete and return the attached Acknowledgment Form within 5 business days to confirm receipt of this notice." For questions or assistance, contact: Regulatory Affairs Manager, Glycar SA (Pty) Ltd, Malcolm Applewhite, [email protected]
Quantity in commerce
18 units
Distribution
US
Product codes and lots
UDI/DI 05414734007269, Lot Number T2506245, exp. 2028.05.25

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0532-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0531-2026Class IOngoingVoluntary: Firm initiated
Z-0532-2026Class IOngoingVoluntary: Firm initiated